RT Journal Article
T1 Visual Performance of Eyes with Residual Refractive Errors after Implantation of an Extended Vision Intraocular Lens
A1 Rementería Capelo, Laureano Álvarez
A1 Contreras Martín, Inés
A1 Morán Ballesteros, Aída
A1 Lorente Hevia, Pilar
A1 Mariñas García, Laura
A1 Ruiz Alcocer, Javier
AB Background. To analyze the tolerance on distance vision of different combined residual astigmatic situations in patients implanted with a novel wavefront shaping extended depth of focus (EDoF) intraocular lens (IOL). Methods. The study included patients implanted with the Acrysof® IQ Vivity® IOL. Uncorrected (UDVA) and corrected distance visual acuity (CDVA) were measured three months after surgery, considering CDVA as the reference situation of the study. Distance VA was also measured in different refractive situations: (A) with 0.50 diopters (D) of positive (myopization) and negative (hyperopization) defocus and (B) with a residual mixed astigmatic refraction induced by adding a combination of −0.25 D spherical and 0.50 D cylindrical lenses placed in vertical (against the rule-ATR), oblique, and horizontal (with the rule-WTR) positions. Results. The study included 30 eyes of 30 patients. UDVA and CDVA were −0.04 ± 0.05 and −0.05 ± 0.05 logMAR, respectively. VA values with +0.50 D and −0.50 D of defocus were 0.01 ± 0.06 and 0.00 ± 0.04 logMAR, respectively. VA was better with distance correction (p<0.001) and no differences were found between the myopic and the hyperopic situations (p=0.09). Distance VA for the ATR, oblique, and WTR astigmatic situations was 0.01 ± 0.05, 0.01 ± 0.06, and 0.01 ± 0.04 logMAR, respectively. VA was better for the reference situation (p<0.001) and no differences were found among the three astigmatic situations (p=0.21). Conclusions. Low residual defocus and mixed astigmatic errors, regardless of its orientation, seem to be tolerated by patients implanted with the studied EDoF IOL. This trial is registered with NCT05392998. Registered 26 May 2022-Retrospectively registered.
PB HINDAWI PUBLISHING CORPORATION
SN 2090-004X
YR 2023
FD 2023-05-04
LK https://hdl.handle.net/20.500.14352/72292
UL https://hdl.handle.net/20.500.14352/72292
LA eng
NO Alcon (Suiza)
DS Docta Complutense
RD 4 abr 2025